SCHEMBL7990480

SCHEMBL7990480

CC1CCN(C(=O)OCc2ccccc2)CC1.Nc1nccc(-n2cnc3ccccc32)n1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LCK P06239 7/20 0.60
ROCK1 Q13464 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.45
CYP2C19 P33261 1/20 0.45
GRIN2B Q13224 4/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MKNK2 Q9HBH9 1/20 0.44
MAP3K14 Q99558 1/20 0.43
IDH1 O75874 1/20 0.43
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
FAAH O00519 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571215 0.84 LCK (0.60) LCKSMN1; SMN2CYP2C19GRIN2BNPC1
SCHEMBL7505588 0.81 LCK (0.62) LCKSMN1; SMN2GRIN2BNPC1RAB9A
SCHEMBL7505777 0.80 LCK (0.82) LCKGRIN2BCYP2D6CYP2C9
SCHEMBL7506273 0.78 LCK (0.67) LCKMKNK2
SCHEMBL7502002 0.78 LCK (0.66) LCKMKNK2IDH1
SCHEMBL7508722 0.77 LCK (0.91) LCKGRIN2BCYP2D6CYP2C9
SCHEMBL4760522 0.75 SMN1; SMN2 (0.74) SMN1; SMN2CYP2C19GRIN2BNPC1RAB9A
SCHEMBL7984542 0.75 LCK (1.00) LCKIDH1
SCHEMBL7504210 0.74 LCK (1.00) LCKGRIN2BMKNK2
SCHEMBL7500544 0.73 LCK (0.85) LCKGRIN2BMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed